Stoke Therapeutics
STOK
$13.90
Share price
-0.93%
Change (1 day)
23.34%
Change (1 year)
Categories
Stoke Therapeutics (STOK) - P/B ratio
P/B ratio as of May 2024 : 4.58
According to Stoke Therapeutics's latest financial reports the company has a price-to-book ratio of 4.58.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Stoke Therapeutics - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.47 | -25.24% |
| 2022-12-31 | 1.97 | -51.57% |
| 2021-12-31 | 4.07 | -48.66% |
| 2020-12-31 | 7.92 | 90.95% |
| 2019-12-31 | 4.15 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.71 | -40.78% | 🇺🇸 USA |